1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 27
2.1.3 Impact of Russia-Ukraine Conflict 29
2.1.4 Impact of Israel-Palestine War 31
2.2 Major Growth Drivers 32
2.3 Market Restraints and Challenges 38
2.4 Emerging Opportunities and Market Trends 41
2.5 Porter's Fiver Forces Analysis 44
3 Segmentation of Global Market by Nutrient Type 48
3.1 Market Overview by Nutrient Type 48
3.2 Amino Acids 51
3.3 Carbohydrates 52
3.4 Trace Elements 53
3.5 Lipid Emulsion 54
3.6 Vitamins and Minerals 55
3.7 Other Nutrient Types 56
4 Segmentation of Global Market by Dosage Form 57
4.1 Market Overview by Dosage Form 57
4.2 Ampules 60
4.3 Bags 61
4.4 Bottles 62
4.5 Vials 63
5 Segmentation of Global Market by Indication 64
5.1 Market Overview by Indication 64
5.2 Short-Term 67
5.3 Long-Term 68
6 Segmentation of Global Market by Patient Group 69
6.1 Market Overview by Patient Group 69
6.2 Pediatric Patients 72
6.3 Adult Patients 73
6.4 Geriatric Patients 74
7 Segmentation of Global Market by End User 75
7.1 Market Overview by End User 75
7.2 Hospitals 78
7.3 Clinics & Ambulatory Care Settings 79
7.4 Homecare 80
7.5 Other End Users 81
8 Segmentation of Global Market by Distribution Channel 82
8.1 Market Overview by Distribution Channel 82
8.2 Retail Stores 85
8.3 Pharmacies & Drug Stores 86
8.4 Online Channels 87
8.5 Other Distribution Channels 88
9 Segmentation of Global Market by Region 89
9.1 Geographic Market Overview 2023-2033 89
9.2 North America Market 2023-2033 by Country 94
9.2.1 Overview of North America Market 94
9.2.2 U.S. 98
9.2.3 Canada 101
9.2.4 Mexico 103
9.3 European Market 2023-2033 by Country 105
9.3.1 Overview of European Market 105
9.3.2 Germany 109
9.3.3 U.K. 111
9.3.4 France 113
9.3.5 Spain 115
9.3.6 Italy 117
9.3.7 Russia 119
9.3.8 Rest of European Market 121
9.4 Asia-Pacific Market 2023-2033 by Country 123
9.4.1 Overview of Asia-Pacific Market 123
9.4.2 Japan 127
9.4.3 China 130
9.4.4 Australia 132
9.4.5 India 134
9.4.6 South Korea 136
9.4.7 Rest of APAC Region 138
9.5 South America Market 2023-2033 by Country 140
9.5.1 Argentina 144
9.5.2 Brazil 146
9.5.3 Chile 148
9.5.4 Rest of South America Market 150
9.6 MEA Market 2023-2033 by Country 151
9.6.1 Turkey 155
9.6.2 Saudi Arabia 157
9.6.3 South Africa 159
9.6.4 Other National Markets 161
10 Competitive Landscape 162
10.1 Overview of Key Vendors 162
10.2 New Product Launch, Partnership, Investment, and M&A 166
10.3 Company Profiles 167
AbbVie Inc. 167
Aculife Healthcare Private Limited 169
Albert David Limited 170
Amanta Healthcare Ltd. 171
American Regent Inc. 172
B. Braun Melsungen AG 173
Baxter International Inc. 174
BML Parenteral Drugs 175
Claris Lifesciences Limited 176
Eurofarma 177
EuroLife Healthcare Pvt. Ltd. 178
Farmoterapica 179
Fresenius Kabi AG 180
Grifols S.A. 181
ICU Medical Inc. 182
JW Pharmaceuticals 183
Otsuka Pharmaceutical Factory Inc. 184
Pfizer Inc. 185
REVIV 186
Sichuan Kelun Pharmaceutical Co., Ltd. 187
Soleo Health 188
Vifor Pharma Management Ltd. 189
11 Investing in Parenteral Nutrition Industry: Risk Assessment and Management 190
11.1 Risk Evaluation of Global Market 190
11.2 Critical Success Factors (CSFs) 196
RELATED REPORTS 199